The 8th Conference on the Molecular Biology of Hearing & Deafness

描述（由申请人提供）：听力和耳聋分子生物学会议（MBHD）要求部分支持。这一系列会议自1992年以来一直成功举行，这有力地说明今后的会议将继续取得成功。第八届会议将于2011年7月6日至9日在英国剑桥附近欣克斯顿的桑格研究所的欢迎信托会议中心举行。对这次会议的支持将用于减少美国学生/博士后研究员和代表性不足的少数民族科学家的出席费用，因为目前对此类旅行的支持仅限于英国和欧洲候选人。还要求支持将于2013年10月在加州拉霍亚举行的第9次会议和将于2015年在英国举行的第10次会议。具体目标促进分子生物学新兴领域的研究。目前这些包括：大规模平行测序，下一代测序；表观遗传学;比较基因组学；由于技术的进步和序列数据的积累，它们最近经历了显著的增长。2. 回顾与听力和耳聋相关的分子生物学进展，邀请参与近期重大研究的科学家发表他们的成果，并通过征集与听觉系统相关的分子水平研究的免费论文。3. 促进从事分子听觉研究的不同实验室之间的互动和合作，以及耳聋分子生物学和分子遗传学相关兴趣的基础科学家和临床医生之间的互动和合作。4. 促进可导致听力障碍的诊断和治疗的转化研究。5. 鼓励未被充分代表的少数民族的受训者和科学家进入听力和耳聋分子生物学领域。6. 为当地的患者、患者权益团体、临床医生和学校提供外联服务，开展耳聋遗传学和听力研究方面的教育。

DESCRIPTION (provided by applicant): Partial support is requested for Conferences on the Molecular Biology of Hearing and Deafness (MBHD). This series of meetings has been held successfully since 1992, which argues strongly for the continued success of the future Conferences. The 8th Conference will occur at the Welcome Trust Conference Center at the Sanger Institute in Hinxton, near Cambridge, U.K., on July 6-9, 2011. Support for this conference would be used to reduce the cost of attendance for U.S. students/ postdoctoral fellows and under-represented minority scientists, since existing support for such travel is restricted to U.K. and European candidates. Support is also requested for the 9th Conference, to be held in La Jolla, CA in October of 2013, and the 10th Conference, to be held in the U.K. in 2015. Specific Aims 1. To promote research in emerging areas of molecular biology. These currently include: massively parallel, next-generation sequencing; epigenetics; and comparative genomics; which have experienced significant recent growth due to technical advances and accumulating sequence data. 2. To review progress in molecular biology related to hearing and deafness by inviting scientists involved in significant recent research to present their results, and by soliciting free papers reporting research at the molecular level related to the auditory system. 3. To facilitate interaction and collaboration between different laboratories engaged in molecular auditory research, as well as between basic scientists and clinicians with related interests in the molecular biology and molecular genetics of deafness. 4. To promote translational research that can lead to diagnostics and therapeutics for the treatment of hearing disorders. 5. To encourage trainees and scientists from under-represented minorities to enter careers in the molecular biology of hearing and deafness. 6. To provide outreach to patients, patient advocacy groups, clinicians and schools in the local area, for education in the genetics of deafness and hearing research.